Company News for November 8, 2022

  • Shares of Haemonetics Corp. HAE rose 3.6% after reporting adjusted earnings per share of $0.83 in the second quarter of fiscal 2022, beating Zacks’ consensus estimate of $0.70.
  • Shares of Affiliated Managers Group Inc. AMG soared 11.4% after posting adjusted earnings per share of $4.21 in the third quarter of 2023, beating Zacks’ consensus estimate of $3.92.
  • NI shares of NiSource Inc. fell 5.9% after the company reported third quarter 2022 adjusted earnings per share of $0.10, missing the Zacks consensus estimate of $0.11.
  • Palantir Technologies Inc. PLTR shares fell 11.5% after the company reported third-quarter 2022 adjusted earnings per share of $0.01, lagging Zacks’ consensus estimate of 0.02 $.

Zacks names ‘only one best choice for doubling up’

From thousands of stocks, 5 Zacks experts have each picked their favorite to skyrocket by +100% or more in the coming months. Of these 5, Research Director Sheraz Mian selects one to have the most explosive advantage of all.

It’s a little-known chemical company that’s up 65% year-on-year, but still very cheap. With relentless demand, rising earnings estimates for 2022 and $1.5 billion for stock buybacks, retail investors could jump in at any moment.

This company could rival or surpass other recent Zacks stocks which are expected to double like Boston Beer Company which jumped +143.0% in just over 9 months and NVIDIA which jumped +175.9% in one year .

Free: See our best stock and our 4 finalists >>

Want the latest recommendations from Zacks Investment Research? Today you can download 7 best stocks for the next 30 days. Click to get this free report

NiSource, Inc (NI): Free Stock Analysis Report

Haemonetics Corporation (HAE): Free Stock Analysis Report

Affiliated Managers Group, Inc. (AMG): Free Stock Analysis Report

Palantir Technologies Inc. (PLTR): Free Stock Analysis Report

To read this article on, click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Karen J. Nelson